The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The demand for diagnostic and therapeutic services for obstructive sleep apnoea syndrome (OSAS) showed marked growth during the 1990s. This paper analyses the long-term cost-effectiveness of nasal continuous positive airway pressure (nCPAP) treatment in comparison to conventional null treatment. A Markov model was used to represent the natural history of OSAS based upon published evidence. Utility values came from a survey of OSAS patients. Data on health costs were collected from hospitals in the Basque Country, Spain. The incremental cost-effectiveness ratio of nCPAP treatment is <6,000 Euros per quality-adjusted life year. On disaggregated analysis, nCPAP treatment accounts for 86% of incremental costs; 84% of incremental effectiveness is attributable to improved quality of life. Treatment of obstructive sleep apnoea syndrome with nasal continuous positive airway pressure has a cost-effectiveness that is in line with that of other commonly funded treatments such as antihypertensive drugs. The key clinical benefit of nasal continuous positive airway pressure treatment is improvement in the quality of life of patients with obstructive sleep apnoea syndrome. This benefit is also precisely the one for which the evidence base is strongest. The remaining uncertainties concerning the impact of nasal continuous positive airway pressure on long-term mortality have only a relatively small impact on the economics of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401 · cited 1×
“In these analyses, the pretreatment patient utility value was used throughout and the utility gain, or effect size, of the treatment [ 41 ] was allowed to vary because the main driving force in the economic assessment is the difference 517”
MethodLongitudinal Study of Moderate Weight Change and Sleep-Disordered Breathing
Peppard, P. E. (2000) · JAMA · doi:10.1001/jama.284.23.3015 · Cited by 2,020
DURÁN, J., ESNAOLA, S., RUBIO, R., & IZTUETA, Á. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.2005065 · Cited by 1,407
An Instrument to Measure Functional Status Outcomes for Disorders of Excessive Sleepiness
(1997) · Sleep · doi:10.1093/sleep/20.10.835 · Cited by 881
Newman, A. B. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.1.50 · Cited by 603
Cited by
Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing
Jennum, P., & Riha, R. L. (2009) · European Respiratory Journal · doi:10.1183/09031936.00180108 · Cited by 319
Duran-Cantolla, J., Aizpuru, F., Montserrat, J. M., Ballester, E., Teran-Santos, J., Aguirregomoscorta, J. I., Gonzalez, M., Lloberes, P., Masa, J. F., De La Pena, M., et al. (2010) · BMJ · doi:10.1136/bmj.c5991 · Cited by 257
Chai-Coetzer, C. L., Antic, N. A., Rowland, L. S., Catcheside, P. G., Esterman, A., Reed, R. L., Williams, H., Dunn, S., & McEvoy, R. D. (2011) · Thorax · doi:10.1136/thx.2010.152801 · Cited by 233
“Treatment of OSA can reduce the health-related consequences of disease(7) 8 and is highly cost-effective.(9) Despite increasing awareness of its adverse health consequences, OSA remains significantly underdiagnosed.”
BackgroundGuest, J. F., Helter, M. T., Morga, A., & Stradling, J. R. (2008) · Thorax · doi:10.1136/thx.2007.086454 · Cited by 117
“concordant with those from four other studies, all of which found CPAP to be a cost-effective treatment.(9) 24–26 Sensitivity analyses showed that the relative cost-effectiveness of CPAP is”
MethodResult
Metadata
- Authors
- Mar, J., Rueda, J. R., Durán-Cantolla, J., Schechter, C., & Chilcott, J.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2003-03
- Volume
- 21
- Issue
- 3
- Pages
- 515-522
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2139227400
- Cited by
- 108
- References
- 13
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. https://app.cochat.ai/papers/10.1183/09031936.03.00040903
- The paper
- Mar, J., Rueda, J. R., Durán-Cantolla, J., Schechter, C., & Chilcott, J. (2003). The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. European Respiratory Journal. https://doi.org/10.1183/09031936.03.00040903
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.